{"url":"https://lda.senate.gov/api/v1/filings/7ff9b9d4-97dc-47df-94cb-e5fc9daf0a28/","filing_uuid":"7ff9b9d4-97dc-47df-94cb-e5fc9daf0a28","filing_type":"RR","filing_type_display":"Registration","filing_year":2015,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/7ff9b9d4-97dc-47df-94cb-e5fc9daf0a28/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Gary Buehler","dt_posted":"2015-06-17T13:41:16-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"21 South Valley Forge Road","registrant_address_2":"Unit 105","registrant_different_address":null,"registrant_city":"Lansdale","registrant_state":"PA","registrant_zip":"19446","registrant":{"id":401103724,"url":"https://lda.senate.gov/api/v1/registrants/401103724/","house_registrant_id":42970,"name":"GARY BUEHLER","description":"Consultant","address_1":"21 South Valley Forge Road","address_2":"Unit 105","address_3":null,"address_4":null,"city":"Lansdale","state":"PA","state_display":"Pennsylvania","zip":"19446","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"WILLIAM J. FARAH","contact_telephone":"+1 202-517-7199","dt_updated":"2022-04-06T16:06:59.322086-04:00"},"client":{"id":200014,"url":"https://lda.senate.gov/api/v1/clients/200014/","client_id":12,"name":"TEVA PHARMACEUTICALS USA, INC.","general_description":"Pharmaceutical Research and Manufacturing","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-05-06"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Section 505(b)(2) new drug applications and exclusivity period.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":62191,"prefix":null,"prefix_display":null,"first_name":"GARY","nickname":null,"middle_name":null,"last_name":"BUEHLER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[{"name":"TEVA PHARMACEUTICAL INDUSTRIES LTD.","contribution":"0.00","ownership_percentage":"100.00","address":"5 Basel Street","city":"Petach Tivka","state":null,"state_display":null,"country":"IL","country_display":"Israel","ppb_city":null,"ppb_state":null,"ppb_state_display":null,"ppb_country":"IL","ppb_country_display":"Israel"},{"name":"TEVA PHARMACEUTICALS EUROPE BV","contribution":"0.00","ownership_percentage":"100.00","address":"PO 306","city":"Mijdrecht","state":null,"state_display":null,"country":"NL","country_display":"Netherlands","ppb_city":null,"ppb_state":null,"ppb_state_display":null,"ppb_country":"NL","ppb_country_display":"Netherlands"},{"name":"ORVET UK","contribution":"0.00","ownership_percentage":"100.00","address":"Leeds Business Park, 18 Brutcliffe Way","city":"Morely Leeds","state":null,"state_display":null,"country":"GB","country_display":"United Kingdom","ppb_city":null,"ppb_state":null,"ppb_state_display":null,"ppb_country":"GB","ppb_country_display":"United Kingdom"}],"affiliated_organizations":[]}